The location of SK3 in cholesterol-enriched membrane nanodomains, also known as lipid rafts, with a function dependent on the lipid environment, provides an opportunity for the control of prostate cancer aggressiveness. This evidence concerns the gene KCNN3 and Familial prostate cancer.